THE BEST SIDE OF API MANUFACTURING

In case the failure to meet CGMP results in the distribution of a drug that does not provide the gain as labeled due to the fact, for instance, it's way too minimal active ingredient, the organization could subsequently recall that product or service.Has the validation or product development group decided the classification of the raw product? Why